After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Mind Medicine Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Mind Medicine Inc is $1.15B. A total of 1.78 million shares were traded on the day, compared to an average of 1.75M shares.
In the most recent transaction, Sullivan Mark sold 11,278 shares of MNMD for 9.77 per share on Sep 25 ’25. After the transaction, the Chief Legal Officer now owns 293,852 company shares. In a previous transaction on Sep 25 ’25, Barrow Robert sold 25,797 shares at 9.77 per share. MNMD shares that Chief Executive Officer owns now total 804,268.
Among the insiders who sold shares, Karlin Daniel disposed of 7,704 shares on Sep 25 ’25 at a per-share price of $9.77. This resulted in the Chief Medical Officer holding 430,625 shares of MNMD after the transaction. In another insider transaction, MARK SULLIVAN bought 11,278 shares at $9.77 per share on Sep 25 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, MNMD has a high of $14.43 and a low of $4.70.
As of this writing, MNMD has an earnings estimate of -$0.54 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.45 per share and a lower estimate of -$0.74. The company reported an EPS of -$0.41 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. MNMD’s latest balance sheet shows that the firm has $133.54M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $10.41M in liabilities at the time. Its Book Value Per Share was $1.70, while its Total Shareholder’s Equity was $151.66M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MNMD is Buy with a score of 4.69.
